𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: A retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program

✍ Scribed by Evan A. Stein; Donald G. Vidt; James Shepherd; Valerie A. Cain; Deborah Anzalone; Michael D. Cressman


Book ID
118063716
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
781 KB
Volume
221
Category
Article
ISSN
0021-9150

No coin nor oath required. For personal study only.